T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 181 clinical trials
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection

Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV …

  • 0 views
  • 18 Feb, 2021
  • 1 location
The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

The role of autologous stem cell transplantation (ASCT) in the first remission (CR1 & PR1) of peripheral T-cell lymphomas (PTCLs) is not well defined. This study analyzed the impact of ASCT on the clinical outcomes of patients with newly diagnosed PTCL in CR1 and PR1.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

The purpose of this survey is to examine the safety of adult patients with relapsed or refractory CD30-positive peripheral T-cell lymphoma (PTCL) (excluding anaplastic large cell lymphoma (ALCL

refractory lymphoma
brentuximab vedotin
large cell lymphoma
hodgkin's disease
brentuximab
  • 2 views
  • 15 Feb, 2021
  • 1 location
Allo-HSCT as First-line Consolidation in High-risk PTCL

Results of conventional therapy in patients with peripheral T-cell lymphoma(PTCL) are poor. Allogeneic hematopoietic stem cell transplantation(allo-HSCT) gave excellent results in PTCL after

peripheral t-cell lymphoma
cell transplantation
cancer
t-cell lymphoma
stem cell transplantation
  • 2 views
  • 25 Jan, 2021
  • 1 location
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides

This is a single-arm, non-randomized feasibility study designed to find out if the laser light-based imaging test called Biodynamic imaging (BDI) can correctly predict the cutaneous T-cell

mycosis
metastatic tumor
cancer
systemic therapy
topical steroids
  • 2 views
  • 23 Jan, 2021
  • 1 location
Blood Urine and Tissue Collection for Cutaneous Lymphoma Eczema and Atopic Dermatitis Research

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

skin biopsy
eczema
cutaneous lymphoma
lymphoma
t-cell lymphoma
  • 75 views
  • 27 Jan, 2021
  • 1 location
T Cell Repertoire Analysis of Immune Mediated Skin Diseases

This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge …

skin disorder
psoriasis
skin disease
mycosis
  • 90 views
  • 24 Jan, 2021
  • 1 location
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

EXALT-2 is a prospective, randomized, three arm study for treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice

  • 0 views
  • 24 Jan, 2021
  • 1 location
The Influence of Extracorporeal Photopheresis on Skin Sclerosis

after receiving FDA approval in 1988. Extracorporeal photopheresis was initially used for the treatment of T-cell lymphoma. Since its introduction, indications for initiating ECP were continuously

  • 0 views
  • 21 Feb, 2021
Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

The investigators designed a compassionate basis phase II study for refractory/relapsed mycosis fungoides/Sezary syndrome consisting of alemtuzumab (Campath) for primary evaluation of overall response and time to relapse. Other goals to consider are toxicity and time to new therapy.

sezary syndrome
campath
mycosis
renal function test
mycosis fungoides and sezary syndrome
  • 54 views
  • 07 Nov, 2020
  • 1 location